Recursion Pharmaceuticals, Inc. is a biotechnology company. Recursion combines experimental biology and bioinformatics with artificial intelligence (AI) in a parallel system to identify treatments quickly and efficiently for any disease which can be modeled at the cellular level.
This report provides insights into Recursion Pharmaceuticals, Inc., including an overview of the company and its product offering, detailed coverage of its business model and operations, information on its funding and partnerships, and biographies of its senior management.
This report provides insights into Recursion Pharmaceuticals, Inc., including an overview of the company and its product offering, detailed coverage of its business model and operations, information on its funding and partnerships, and biographies of its senior management.
Reasons to Buy
- Gain insights into Recursion Pharmaceuticals, Inc. business operations.
- Gain insights into its partnerships and funding.
- Gain an understanding of its technology focus.
Table of Contents
- Company Overview
- Technology Focus
- Product Overview
- Partnership
- Funding
- Key Employees
- Appendix
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Roche
- Genentech
- Mila
- Bayer
- University of Utah
- Takeda Pharmaceutical
- Ohio State Innovation Foundation
- UC San Diego School of Medicine
- Splunk
